By Market News Video Staff, Monday, October 25, 10:08 AM ET
There are 7,884,900 shares short of the iShares Nasdaq Biotechnology Index Fund (NASDAQ:IBB) according to data provided to ETFChannel.com from ShortSqueeze.com on ETFChannel's Most Shorted ETFs toplist.
With 15.8 million shares outstanding, this means that 46.79% of IBB shares are shorted, making it the 15th most shorted ETF that ETFChannel covers.
Top holdings of this ETF include Amgen (NASDAQ:AMGN), Teva Pharmaceuticals (NYSE:TEVA), Celgene (NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD).
It would take approximately 10.7 days for shorts to cover the shorted shares of IBB.
Register Today to be alerted when we launch, and we'll offer you a 20% discount on your first year of service! The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors — anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.
This Article's Word Cloud:AmgenBiotechnologyCelgeneETFChannelETFsGileadInvestmentMostPharmaceuticalsPortfolioRegisterSciencesTEVATodayWILLWithalertedallowsassetbondsclassescompletelycountriescoverdaysdesignedfirstgrowthincludeleadsmakingmillionmostoutstandingportfolioprogramservicesharesshortshortedstockstermsthattherethistoplistwhenwouldyearyour
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.